首页> 美国卫生研究院文献>The Journal of Biological Chemistry >Low Density Lipoprotein (LDL) Receptor-related Protein 6 (LRP6) Regulates Body Fat and Glucose Homeostasis by Modulating Nutrient Sensing Pathways and Mitochondrial Energy Expenditure
【2h】

Low Density Lipoprotein (LDL) Receptor-related Protein 6 (LRP6) Regulates Body Fat and Glucose Homeostasis by Modulating Nutrient Sensing Pathways and Mitochondrial Energy Expenditure

机译:低密度脂蛋白(LDL)受体相关蛋白6(LRP6)通过调节营养传感途径和线粒体能量消耗来调节体内脂肪和葡萄糖体内稳态

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Body fat, insulin resistance, and type 2 diabetes are often linked together, but the molecular mechanisms that unify their association are poorly understood. Wnt signaling regulates adipogenesis, and its altered activity has been implicated in the pathogenesis of type 2 diabetes and metabolic syndrome. LRP6+/− mice on a high fat diet were protected against diet-induced obesity and hepatic and adipose tissue insulin resistance compared with their wild-type (WT) littermates. Brown adipose tissue insulin sensitivity and reduced adiposity of LRP6+/− mice were accounted for by diminished Wnt-dependent mTORC1 activity and enhanced expression of brown adipose tissue PGC1-α and UCP1. LRP6+/− mice also exhibited reduced endogenous hepatic glucose output, which was due to diminished FoxO1-dependent expression of the key gluconeogenic enzyme glucose-6-phosphatase (G6pase). In addition, in vivo and in vitro studies showed that loss of LRP6 allele is associated with increased leptin receptor expression, which is a likely cause of hepatic insulin sensitivity in LRP6+/− mice. Our study identifies LRP6 as a nutrient-sensitive regulator of body weight and glucose metabolism and as a potential target for pharmacological interventions in obesity and diabetes.
机译:人体脂肪,胰岛素抵抗和2型糖尿病经常联系在一起,但统一它们之间联系的分子机制却鲜为人知。 Wnt信号调节脂肪形成,其活性的改变已被认为与2型糖尿病和代谢综合征的发病机制有关。与野生型(WT)同窝仔相比,高脂饮食的LRP6 + /-/ sup>小鼠可防止饮食引起的肥胖症以及肝脏和脂肪组织的胰岛素抵抗。褐色脂肪组织胰岛素敏感性和LRP6 +/-小鼠的肥胖减少归因于Wnt依赖性mTORC1活性的降低和褐色脂肪组织PGC1-α和UCP1表达的增强。 LRP6 +/- 小鼠还表现出减少的内源性肝葡萄糖输出,这是由于关键的糖异生酶葡萄糖-6-磷酸酶(G6pase)的FoxO1依赖性表达减少所致。此外,体内和体外研究表明,LRP6等位基因的缺失与瘦素受体表达增加有关,瘦素受体表达可能是LRP6 +/- 小鼠肝胰岛素敏感性的原因。我们的研究确定LRP6是体重和葡萄糖代谢的营养敏感调节剂,并且是肥胖症和糖尿病药物治疗的潜在靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号